Advertisement

Topics

Companies Related to "University Eastern Finland Release Antiulcer Drugs Increase Risk" [Most Relevant Company Matches] RSS

03:34 EDT 23rd September 2017 | BioPortfolio

Here are the most relevant search results for "University Eastern Finland Release Antiulcer Drugs Increase Risk" found in our extensive corporate database of over 50,000 company records.

Showing "University Eastern Finland Release Antiulcer Drugs Increase Risk" Companies 1–25 of 4,400+

Wednesday 20th September 2017

Viceroy Research

Viceroy Research is an investigative financial research group. As global markets become more opaque and complex, and traditional gatekeepers and safeguards often compromised, investors and shareholders are at greater risk than ever of being misled or uninformed by public companies and their promoters and sponsors. Our mission is to sift fact from fiction a...


Cellular Dynamics International (CDI)

Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development and personalized medicine applications. CDI harnesses the power of pluripotent stem cells and their ability to differentiate into any cell type for world-class drug development tools. In addition, it is the leader in iPS technology, the production of pluripotent stem ...

Arcus Biosciences

Arcus Biosciences (“Arcus”) is a biotechnology company focused on the discovery and development of innovative cancer immunotherapies. Arcus was founded in 2015 by Terry Rosen and Juan Jaen, the co-founders of Flexus Biosciences, which in February 2015 was acquired by Bristol-Myers Squibb to access Flexus’s IDO inhibitor, which was in preclinical...


Tuesday 19th September 2017

Archway Health

Archway Health, founded in 2014 and built on a deep foundation of healthcare payment reform expertise, works with providers to design and execute care and risk management initiatives that drive success in bundled payment programs. Archway is currently working with leading healthcare providers participating in the CMS BPCI and OCM programs, as well as with ...

Raiven Healthcare

Providers use the Raiven Healthcare real-time, predictive analytics platform for complex health treatments, accessing the artificial intelligence (AI) tools to help determine the clinical treatment path that will deliver the best outcome at the optimum cost for a specific patient. The company’s groundbreaking technology has improved outcomes by 40% wh...

Monday 18th September 2017

Aspect Biosystems Ltd.

Aspect Biosystems is operating at the leading edge of 3D bioprinting and tissue engineering. The company’s proprietary Lab-on-a-Printer™ platform technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on ...

Boehringer Ingelheim GmbH

Boehringer Ingelheim is a research-driven group of companies dedicated to researching, developing, manufacturing and marketing pharmaceuticals that improve health and quality of life.Our business consists of Prescription Medicines, Consumer Health Care and Animal Health. Activities grouped under Industrial Customer include Biopharmaceuticals and Chemicals.We focus on the production of innovative d...

Friday 15th September 2017

Rare Disease Communications®

Rare Disease Communications® is a health care communications and media company focused on the rare disease community and dedicated to raising awareness of rare diseases and orphan drugs so that patients will be diagnosed and treated more efficiently. Rare Disease Communications® is part of the Michael J. Hennessy Associates, Inc. family of businesses, ...

Wednesday 13th September 2017

Energid Technologies

Energi is a Peabody, Massachusetts-based industrial reinsurance company that provides specialized insurance and risk management products to targeted market segments of the North American energy industry. The core programs include fuel distribution, fuel transport, energy construction, agricultural cooperatives, renewable energy, energy efficiency, utilitie...

Tuesday 12th September 2017

Kaneka Eurogentec

Eurogentec was founded in 1985 as a spin-off company of the University of Liège (Belgium). Kaneka Eurogentec contributes to improving health and fighting diseases by supplying products and services to scientists involved in life science research, molecular diagnostics, and therapeutic developments. The Liège-based company is recognised as one of the ...

Braggawatt Energy

Braggawatt is a data and analytics company whose end-to-end origination and financing platform helps integrators connect small and mid-sized distributed energy projects with smart financing options, allowing end-customers to immediately benefit from energy cost savings and investors to secure superior, risk-adjusted returns at scale. Braggawatt’s plat...

NanOlogy, LLC

NanOlogy, LLC (www.nanology.us) is a company formed by DFB Pharmaceuticals, LLC of Fort Worth, TX, CritiTech, Inc. of Lawrence, KS, and US Biotest, Inc. of San Luis Obispo, CA, to finance and clinically develop a patented nanoparticle technology platform for local, sustained delivery of proven drugs aimed at increasing their safety and efficacy in the trea...

Monday 11th September 2017

OZMOSI

Established in 2013, OZMOSI is a privately-held business intelligence firm based in New Jersey, providing strategic support, competitive analysis and product/portfolio forecasting solutions in the pharmaceutical industry. By applying their proprietary models, OZMOSI supports its Global Pharma and Biotech clients in making decisions with confidence about th...

Thursday 7th September 2017

OLIGOMERIX, Inc.

OLIGOMERIX, Inc. is a biopharmaceutical company founded in 2006 located within the Audubon Biomedical Science and Technology Park of Columbia University. The Company is exploiting its novel research that allows rapid generation of stable amyloid oligomers as targets for drug discovery. These systems will enable target identification and validation, and drug discovery for Alzheimer's and other neur...

NewLink Genetics Corporation

NewLink Genetics Corporation is a biopharmaceutical company developing novel drugs and functional genomics solutions with a primary focus on cancer.The successful completion of the Human Genome Project signals a new age in medical discovery centered on protein research. The rapidly growing knowledge base of the human genome provides an unprecedented opportunity to launch a revolutionary paradigm ...

Lyndra, Inc.

Lyndra aims to fundamentally change the way patients take medicines through the development of oral, ultra-long-acting, sustained release oral therapies that drastically improve healthcare outcomes. The Lyndra platform was developed at the Massachusetts Institute of Technology, in the laboratory of Dr. Robert Langer in collaboration with the Bill and Melin...

Wednesday 6th September 2017

Cerebrotech Medical Systems

Cerebrotech Medical Systems, Inc., is a venture capital-backed company dedicated to designing neurotechnology solutions to improve the care of brain-injured patients worldwide. The company is developing a portable, noninvasive neuro-monitoring device that allows for earlier detection of potentially life-threatening conditions such as large vessel occlusion...

Notable Labs

Notable Labs’ mission is to change the way cancer is treated, which starts with putting patients first. The company is developing a personalized treatment service for people with cancer that prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor. Focusing on individual patients and existing treatments, the c...

Tuesday 5th September 2017

Protembis GmbH

Founded in 2013, Protembis is a medical device start-up company with its R&D base in the engineering and technology city of Aachen, Germany. The company’s vision is to bring the ProtEmbo® System into every interventional procedure which bears a risk of neurologic injury, thereby radically improving patient safety. Protembis is sponsored by Germany...

Friday 1st September 2017

Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction. The Company's lead drug candidate, Piclidenoson, is scheduled to enter Phase III trials in 2...

Monday 28th August 2017

Xontogeny LLC

Xontogeny was founded by industry veteran Chris Garabedian and launched with a $25M Series A round in May 2017. The company, based in Boston, MA, seeks to support and accelerate the development of life science technologies from early development through clinical proof-of-concept. Xontogeny provides entrepreneurs with the leadership, strategic guidance and ...

Thursday 24th August 2017

ISACA

Nearing its 50th year, ISACA® (isaca.org) is a global association helping individuals and enterprises achieve the positive potential of technology. Today’s world is powered by technology, and ISACA equips professionals with the knowledge, credentials, education and community to advance their careers and transform their organizations. ISACA leverage...

Wednesday 23rd August 2017

Streamline Healthcare Solutions

Since the 1970’s, Comprehensive Healthcare has been providing services to children, adults and families throughout Eastern Washington. Comprehensive is a private, non-profit organization that offers a full range of behavioral health and substance abuse disorder treatment services, with special programs for veterans, victims of crime, parents and emplo...

Empire BlueCross and BlueShield

Serving New Yorkers for 80 years, Empire BlueCross BlueShield is the largest health insurer in New York supporting more than four million members and more than 38,000 business, union and small employers in New York. Empire BlueCross BlueShield (Empire) is the trade name of Empire HealthChoice Assurance, Inc., and Empire Blue Cross Blue Shield HMO is the tr...

Turner Impact Capital

Turner Impact Capital is an investment management firm based in Los Angeles focused on creating sustainable solutions for many of today’s societal problems by developing and investing in community-enriching infrastructure in densely-populated, underserved communities. The firm seeks to generate superior risk-adjusted financial returns by investing in ...


More From BioPortfolio on "University Eastern Finland Release Antiulcer Drugs Increase Risk"

Quick Search
Advertisement
 

Corporate Database Quicklinks